LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein. - Chen KL; Huang SW; Yao JJ; He SW; Gong S; Tan XR; Liang YL; Li JY; Huang SY; Li YQ; Zhao Y; Qiao H; et al. (Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2024)